DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on September 22, 2008; DOI: 10.1124/dmd.108.020750


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.108.020750v1
36/12/2434    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poirier, A.
Right arrow Articles by Funk, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poirier, A.
Right arrow Articles by Funk, C.


Received for publication February 4, 2008.
Revised July 17, 2008.
Accepted for publication September 19, 2008.

Design, data analysis and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model

Agnes Poirier 1, Thierry Lave 1, Renee Portmann 1, Marie-Elise Brun 1, Frank Senner 1, Manfred Kansy 1, Hans Peter Grimm 1, Christoph Funk 1*

1 F. Hoffmann-La Roche Ltd.

* Address correspondence to: E-mail: christoph.funk{at}roche.com

Abstract

The use of in vitro data for quantitative predictions of transporter-mediated elimination in vivo, requires an accurate estimation of the transporter Michaelis-Menten parameters, Vmax and Km, as a first step. Therefore, the experimental conditions of in vitro studies used to assess hepatic uptake transport were optimized regarding active transport processes, non-specific binding and passive diffusion (Pdif). A mechanistic model was developed to analyze and accurately describe these active and passive processes. This two-compartmental model was parameterized to account for non-specific binding, bidirectional passive diffusion, and active uptake processes based on the physiology of the cells. The model was used to estimate kinetic parameters of in vitro transport data from organic anion transporting peptide (OATP) model substrates (e.g. CCK8, deltorphin II, fexofenadine, pitavastatin). Data analysis by this mechanistic model significantly improved the accuracy and precision in all derived parameters (mean coefficient of variation for Vmax and Km were respectively 19% and 23%) as compared to the conventional kinetic method of transport data analysis (mean CV% were respectively 58% and 115% using this method). Furthermore, permeability was found to be highly temperature-dependent in CHO control cells and artificial membranes (PAMPA). While for some compounds (taurocholate, estrone-3-sulfate, propranolol) the effect was moderate (1.5 to 6-fold higher permeability at 37°C compared to 4°C), for fexofenadine a 16 fold higher passive permeability was seen at 37°C. Therefore, Pdif was better predicted if evaluated under the same experimental conditions as Vmax and Km, i.e. in a single incubation of CHO over-expressed cells or rat hepatocytes at 37°C, instead of a parallel control evaluation at 4°C.


Key words: ABC transporters, active transport, cellular transport, hepatocytes, liver physiology/models, mathematical modeling, membrane transport, organic anion transport





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.